ASHLEY TYCE: Open Payments
NPI 1558073924 · TAVARES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,151 in 146 payments from 31 companies in 2025. Trend: 2023 $1,527 · 2024 $1,692 · 2025 $3,151
Food & beverage: $3,151
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $364 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $274 |
| Medtronic, Inc. | 2 | $270 |
| AstraZeneca Pharmaceuticals LP | 11 | $219 |
| Esperion Therapeutics, Inc. | 18 | $197 |
| Sumitomo Pharma America, Inc. | 8 | $182 |
| PFIZER INC. | 9 | $161 |
| Viatris Specialty LLC | 8 | $160 |
| Novo Nordisk Inc | 9 | $154 |
| Lilly USA, LLC | 6 | $136 |
Products named: CAPLYTA, NEXLETOL, VRAYLAR, GEMTESA, YUPELRI, PROTEGE RX, ELIQUIS, REXULTI.
Industry payments across FL — which companies pay providers there.
